Disease-modifying drugs in multiple sclerosis.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)

Volumn 17, Issue 50, 2003, Pages 39-45

  Keenan, Elizabeth ^a   Porter, Bernadette ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; GLATIRAMER; IMMUNOLOGICAL ADJUVANT; INTERFERON BETA SERINE; INTERFERON BETA-1B; PEPTIDE;

CLASSIFICATION; HUMAN; METHODOLOGY; MULTIPLE SCLEROSIS; NEUROLOGY; NURSING; ORGANIZATION AND MANAGEMENT; OUTPATIENT DEPARTMENT; PATIENT EDUCATION; REVIEW; SOCIAL SUPPORT;

ADJUVANTS, IMMUNOLOGIC; HUMANS; INTERFERON-BETA; MULTIPLE SCLEROSIS; NEUROLOGY; OUTPATIENT CLINICS, HOSPITAL; PATIENT EDUCATION; PEPTIDES; SOCIAL SUPPORT;

EID: 0142228178     PISSN: 00296570     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)